The Behav­ioral Research and Ther­apy Clin­ics (BRTC) is a clin­i­cal research cen­ter that develops and evaluates new treatments for difficult-to-treat individuals with severe and complex disorders of pervasive emotion dysregulation. The BRTC is particularly committed to developing effective treatments for those patients excluded from behavioral and medication clinical treatment trials due to high risk for suicide, the complexity of multiple co-occurring disorders, and/or history of failure in previous clinical interventions. The pri­mary treat­ment under devel­op­ment at the BRTC is termed Dialec­ti­cal Behav­ior Ther­apy (DBT), which is a cog­ni­tive behav­ioral treat­ment devel­oped by Dr. Mar­sha M. Line­han.

The BRTC also operates as a clinical research training center, preparing graduate students and postdoctoral fellows to become clinician-scientists. Research at the BRTC has been funded-to-date by the National Insti­tute of Health, the Bor­der­line Per­son­al­ity Dis­or­der Research Foun­da­tion, the Ben­nett Fam­ily Foun­da­tion and con­sult­ing income gen­er­ated by research staff.

Learn about Dialectical Behavior Therapy

Dialectical Behavior Therapy (DBT) is a comprehensive cognitive-behavioral treatment developed by Dr. Marsha Linehan over the last 25 years. DBT was originally developed to treat suicidal patients, evolved into a treatment for suicidal BPD patients, and has since been adapted for the treatment of BPD patients with presenting problems other than suicidal behaviors. »Read more